U.S. Markets closed

SpeakEasy Cannabis Club Ltd. Re (39H.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
0.4030+0.0090 (+2.28%)
At close: 1:04PM CEST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3940
Open0.4030
Bid0.3880 x 0
Ask0.4130 x 0
Day's Range0.4030 - 0.4080
52 Week Range0.2080 - 0.5860
Volume0
Avg. Volume25,365
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • SpeakEasy Reports on 2021 Annual General Meeting Results
    CNW Group

    SpeakEasy Reports on 2021 Annual General Meeting Results

    SpeakEasy Cannabis Club Ltd. (CSE: EASY) (Frankfurt: 39H) (the "Company" or "SpeakEasy") a holder of a federal licence to cultivate, process and sell cannabis under the Cannabis Act is pleased to announce that during its Annual General Meeting (the "Meeting") held on April 28, 2021, shareholders approved all agenda items presented, including the election of management's nominees to serve as directors of the Company: William Fleming, Patrick Geen, Frey Garabagi and Charles Williams.

  • SpeakEasy to Enter Psychedelics Sector with Narcotics Dealers Licence with a Focus on Psilocybin
    CNW Group

    SpeakEasy to Enter Psychedelics Sector with Narcotics Dealers Licence with a Focus on Psilocybin

    SpeakEasy Cannabis Club Ltd. (CSE: EASY) (Frankfurt: 39H) (the "Company" or "SpeakEasy") a holder of a federal licence to cultivate, process and sell cannabis under the Cannabis Act is excited to announce it is 4 months into a 6-9 month application process to receiving its Narcotics Dealers License ("NDL") in-order to develop and standardize psilocybin cultivation. A NDL licenced dealer may produce, assemble, sell, provide, transport, send, deliver, import or export a controlled drug (psilocybin) if they comply with the terms and conditions of their dealer's licence and any permit issued under the licence.

  • SpeakEasy Completes Product Menu for Two Upcoming Concentrate Brands
    CNW Group

    SpeakEasy Completes Product Menu for Two Upcoming Concentrate Brands

    SpeakEasy Cannabis Club Ltd. (CSE: EASY) (Frankfurt: 39H) (the "Company" or "SpeakEasy") a holder of a federal licence to cultivate, process and sell cannabis under the Cannabis Act, is pleased to announce that it has completed its product menu for two of its concentrate brands scheduled for release over the next two quarters. In addition, further to its press releases of January 21, 2021 and April 9, 2021, the Company has completed the transactions contemplated by a convertible loan agreement (the "Loan Agreement") among the Company, 10161233 Canada Limited, 1287866 B.C. Ltd. (the "Lender") and Bhayana Ventures Ltd. (the "Administrative Agent") dated April 9, 2021, for aggregate gross proceeds of CDN$3,000,000 (the "Loan").